AR082335A1 - Propiedades antivirales del aloe-vera y tratamiento del sindrome de inmunodeficiencia adquirida (sida) - Google Patents
Propiedades antivirales del aloe-vera y tratamiento del sindrome de inmunodeficiencia adquirida (sida)Info
- Publication number
- AR082335A1 AR082335A1 ARP110102674A ARP110102674A AR082335A1 AR 082335 A1 AR082335 A1 AR 082335A1 AR P110102674 A ARP110102674 A AR P110102674A AR P110102674 A ARP110102674 A AR P110102674A AR 082335 A1 AR082335 A1 AR 082335A1
- Authority
- AR
- Argentina
- Prior art keywords
- aloe
- dihydroxy
- hydroxymethyl
- treatment
- aloinoside
- Prior art date
Links
- 235000011399 aloe vera Nutrition 0.000 title abstract 7
- 208000030507 AIDS Diseases 0.000 title abstract 5
- 235000002961 Aloe barbadensis Nutrition 0.000 title abstract 5
- 244000144927 Aloe barbadensis Species 0.000 title 1
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 abstract 6
- 244000186892 Aloe vera Species 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 4
- 239000002253 acid Substances 0.000 abstract 3
- 241001116389 Aloe Species 0.000 abstract 2
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 abstract 2
- BUPDVJFRVYWYEV-PIVIZACJSA-N Aloinoside A Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OCC1=CC(O)=C(C(=O)C=2C(=CC=CC=2O)[C@@H]2[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C2=C1 BUPDVJFRVYWYEV-PIVIZACJSA-N 0.000 abstract 2
- BUPDVJFRVYWYEV-SGAFVUFDSA-N Aloinoside B Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OCC1=CC(O)=C(C(=O)C=2C(=CC=CC=2O)[C@H]2[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C2=C1 BUPDVJFRVYWYEV-SGAFVUFDSA-N 0.000 abstract 2
- PPYDTOCUFRBPQR-UHFFFAOYSA-N Cascaroside C Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3C(OC4OC(CO)C(O)C(O)C4O)c2c1 PPYDTOCUFRBPQR-UHFFFAOYSA-N 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 2
- 208000037357 HIV infectious disease Diseases 0.000 abstract 2
- AFHJQYHRLPMKHU-OSYMLPPYSA-N aloin A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-OSYMLPPYSA-N 0.000 abstract 2
- 150000004056 anthraquinones Chemical class 0.000 abstract 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 abstract 2
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 abstract 2
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 2
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 abstract 2
- ULQLXEDDKOTIHN-UHFFFAOYSA-N 1-(trihydroxymethyl)anthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2C(O)(O)O ULQLXEDDKOTIHN-UHFFFAOYSA-N 0.000 abstract 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 abstract 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical class CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 239000010282 Emodin Substances 0.000 abstract 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 abstract 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 abstract 1
- FCDLCPWAQCPTKC-UHFFFAOYSA-N Rhein Chemical compound C1=CC=C2C(=O)C3=CC(C(=O)O)=CC(O)=C3C(=O)C2=C1O FCDLCPWAQCPTKC-UHFFFAOYSA-N 0.000 abstract 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 abstract 1
- CPUHNROBVJNNPW-UHFFFAOYSA-N aloin A Natural products OC1C(O)C(O)C(CO)OC1OC1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 CPUHNROBVJNNPW-UHFFFAOYSA-N 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- WUDFEXSJURUGSD-UHFFFAOYSA-N anthracene-1,8-diol Chemical compound C1=CC(O)=C2C=C3C(O)=CC=CC3=CC2=C1 WUDFEXSJURUGSD-UHFFFAOYSA-N 0.000 abstract 1
- 229940098421 anthraquinone glycoside Drugs 0.000 abstract 1
- 229930182482 anthraquinone glycoside Natural products 0.000 abstract 1
- 150000008139 anthraquinone glycosides Chemical class 0.000 abstract 1
- 208000019902 chronic diarrheal disease Diseases 0.000 abstract 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 230000001079 digestive effect Effects 0.000 abstract 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 150000002739 metals Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 230000004580 weight loss Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pediatric Medicine (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Una composición farmacéutica que comprende una combinación de formulaciones derivadas de Aloe vera para el tratamiento del Síndrome de Inmunodeficiencia Adquirida (SIDA) o infección por VIH. La composición comprende: (i) un extracto de polimanano estéril inyectable, (ii) Raidox (antraquinonas de aloe y sus derivados diacetilo), y (iii) un polvo de aloe vera secado por congelamiento, jugo de aloe vera, gel de aloe vera o una combinación de los mismos. También se pueden incluir uno o más suplementos nutricionales que comprenden ácidos grasos, proteínas, minerales y metales, vitaminas, sales, aminoácidos y otros excipientes farmacéuticamente aceptables para combatir la diarrea crónica, las complicaciones digestivas, y la pérdida de peso en algunos pacientes antes y durante el curso del tratamiento. Además, método para el tratamiento del SIDA o de la infección por VIH usando la composición antes mencionada.Reivindicación 7: La composición de la reivindicación 1, en donde la una o más antraquinonas de aloe se seleccionan del grupo que consiste en Aloe-Emodina, 1,8-Dihidroxi-3-(hidroximetil)-9,10-antracenodiona, 1,8-Dihidroxi-3-(hidroximetil)antraquinona, 3-Hidroximetilcrisazina, Aloe-Emodina-Antranol, Aloinósido-A, Aloinósido-B, Aloína-A, 10-Glucopiranosil-1,S-dihidroxi-3-(hidroximetil)-9(10)-antraceno, 1,8-Dihidroxi-3-hidroximetil-10-(6-hidroximetil)-3,4,5-trihidroxi-2-piranosil, antrona, 10-{1’,5’-anhidroglucosil)-aloe-emodin-9-antrona, Barbaloína, Aloína-B Epímero de Aloína-A, lsobarbaloína, Aloinósido-A, Aloinósido-B, Antranoles, Antraquinona-glucósido, Ácido crisamínico, Ácido crisofánico, Crisofanol, Crisofanol-glucósido, 1,8-Dihidroxiantraceno, Emodina, 1,3,8-Trihidroxi-6-metil-9,10-antraceno-diona, 1,3,8-Trihidroxi-6-metilantraquinona, 4,5,7-Trihidroxi-2-metilantraquinona, Frángula emodina, Homonataloína, Hidroximetilantraquinona, Reína, Ácido 9,10-4,5-dihidroxi-9,10-dioxo-2-antraceno-carboxílico, Ácido 1,5-dihidroxiantraquinona-3-carboxílico, Ácido 4,5-dihidroxiantraquanone-2-carboxílico, Ácido crisazin-3-carboxílico, Trihidroximetilantraquinona, y modificaciones y derivados de los mismos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36735810P | 2010-07-23 | 2010-07-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR082335A1 true AR082335A1 (es) | 2012-11-28 |
Family
ID=45494120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110102674A AR082335A1 (es) | 2010-07-23 | 2011-07-22 | Propiedades antivirales del aloe-vera y tratamiento del sindrome de inmunodeficiencia adquirida (sida) |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20120022018A1 (es) |
| EP (1) | EP2595643A4 (es) |
| JP (1) | JP2013531071A (es) |
| KR (1) | KR20130062329A (es) |
| CN (1) | CN103025340B (es) |
| AP (1) | AP2013006738A0 (es) |
| AR (1) | AR082335A1 (es) |
| AU (1) | AU2011282200B2 (es) |
| BR (1) | BR112013001717A2 (es) |
| CA (1) | CA2804622A1 (es) |
| HK (1) | HK1182336A1 (es) |
| MX (1) | MX2013000670A (es) |
| NZ (3) | NZ701262A (es) |
| RU (1) | RU2013100188A (es) |
| SG (1) | SG186999A1 (es) |
| TW (1) | TW201206460A (es) |
| WO (1) | WO2012012513A1 (es) |
| ZA (1) | ZA201300583B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120322757A1 (en) * | 2011-06-14 | 2012-12-20 | Coats Aloe International, Inc. | Methods for Aloe Processing |
| CN105418410B (zh) * | 2015-12-21 | 2017-12-26 | 武汉大学 | 大黄素衍生物及其在制备抗hiv‑1药物中的应用 |
| CA2967506A1 (en) | 2016-01-18 | 2017-07-18 | Nadiah Abdulkarim A. Alessa | Composition for treatment and preventative of the human papilloma virus hpv infection, ulcerations and boils |
| US10322156B2 (en) * | 2016-07-07 | 2019-06-18 | Herbalife International Of America, Inc. | Methods of treatment using purified (decolorized) aloe vera leaf dry juice |
| CN106831397B (zh) * | 2016-12-12 | 2019-07-26 | 东北师范大学 | 一种蒽醌类化合物及其制备方法和医用用途 |
| KR101988757B1 (ko) * | 2017-12-19 | 2019-06-12 | 가톨릭대학교 산학협력단 | 1,2-디하이드록시-3-메틸안트라퀴논을 유효성분으로 하는 간암 예방 또는 치료용 조성물 |
| EP3773612A4 (en) | 2018-03-28 | 2022-01-12 | Herbalife International of America, Inc. | ACETYLATION OF POLYSACCHARIDS |
| CN111320541B (zh) * | 2020-03-26 | 2023-05-26 | 四川大学华西医院 | 一种防治病毒疾病的化合物及其应用 |
| KR20230011537A (ko) | 2021-07-13 | 2023-01-25 | 주식회사 케이제이엠바이오 | 알로에 노루궁뎅이버섯 균사체 발효물 함유 분말의 제조방법 및 이에 따라 제조된 분말을 포함하는 기능성 식품 조성물 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5106616A (en) * | 1988-01-14 | 1992-04-21 | Carrington Laboratories, Inc. | Administration of acemannan |
| US4917890A (en) * | 1985-06-28 | 1990-04-17 | Carrington Laboratories, Inc. | Processes for preparation of aloe products, products produced thereby and compositions thereof |
| US5118673A (en) * | 1982-05-07 | 1992-06-02 | Carrington Laboratories, Inc. | Uses of aloe products |
| US4851224A (en) * | 1986-06-05 | 1989-07-25 | Carrington Laboratories, Inc. | Process for preparation of aloe products |
| US5824659A (en) * | 1996-09-04 | 1998-10-20 | Board Of Regents, The University Of Texas System | Cytoprotective oligosaccharide from Aloe preventing damage to the skin immune system by UV radiation |
| US6083508A (en) * | 1998-05-19 | 2000-07-04 | Avalos; Ramiro Estrada | Method of processing aloe leaves |
| US20040063624A1 (en) * | 1999-04-08 | 2004-04-01 | Andreas Kage | Method of inhibiting the transition of free HIV virus through the cllular mucosal barrier |
| AU2003300167B2 (en) * | 2003-12-31 | 2010-09-16 | K-Pax Vitamins, Inc. | Nutrient compositions and methods for enhanced effectiveness of the immune system |
| CN1284485C (zh) * | 2004-03-16 | 2006-11-15 | 大连理工大学 | 无色透明脱苦稳定芦荟凝胶汁的清洁生产方法 |
| CN1778310A (zh) * | 2004-11-18 | 2006-05-31 | 深圳市武大金球中药现代化工程技术研究中心 | 大黄素、大黄多糖在抗人类免疫缺陷病素(hiv)中的应用 |
| CN101070354B (zh) * | 2007-05-18 | 2010-04-07 | 中南大学 | 一种利用芦荟同时生产芦荟多糖粉、芦荟活性水的方法 |
| US8604187B2 (en) * | 2010-01-14 | 2013-12-10 | North Texas Medical Associates | Compositions and methods of aloe polysaccharides |
-
2011
- 2011-07-20 CN CN201180036096.1A patent/CN103025340B/zh active Active
- 2011-07-20 WO PCT/US2011/044652 patent/WO2012012513A1/en active Application Filing
- 2011-07-20 AP AP2013006738A patent/AP2013006738A0/xx unknown
- 2011-07-20 RU RU2013100188/15A patent/RU2013100188A/ru not_active Application Discontinuation
- 2011-07-20 KR KR1020137004429A patent/KR20130062329A/ko not_active Application Discontinuation
- 2011-07-20 EP EP11810330.8A patent/EP2595643A4/en not_active Withdrawn
- 2011-07-20 NZ NZ701262A patent/NZ701262A/en unknown
- 2011-07-20 US US13/187,222 patent/US20120022018A1/en not_active Abandoned
- 2011-07-20 CA CA2804622A patent/CA2804622A1/en not_active Abandoned
- 2011-07-20 NZ NZ605466A patent/NZ605466A/en unknown
- 2011-07-20 NZ NZ720863A patent/NZ720863A/en unknown
- 2011-07-20 AU AU2011282200A patent/AU2011282200B2/en active Active
- 2011-07-20 MX MX2013000670A patent/MX2013000670A/es active IP Right Grant
- 2011-07-20 BR BR112013001717A patent/BR112013001717A2/pt not_active IP Right Cessation
- 2011-07-20 SG SG2013001748A patent/SG186999A1/en unknown
- 2011-07-20 JP JP2013520831A patent/JP2013531071A/ja active Pending
- 2011-07-22 AR ARP110102674A patent/AR082335A1/es unknown
- 2011-07-22 TW TW100126070A patent/TW201206460A/zh unknown
-
2013
- 2013-01-22 ZA ZA2013/00583A patent/ZA201300583B/en unknown
- 2013-08-22 HK HK13109862.1A patent/HK1182336A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ701262A (en) | 2016-06-24 |
| AU2011282200B2 (en) | 2015-03-19 |
| CN103025340A (zh) | 2013-04-03 |
| CA2804622A1 (en) | 2012-01-26 |
| NZ720863A (en) | 2016-10-28 |
| RU2013100188A (ru) | 2014-08-27 |
| KR20130062329A (ko) | 2013-06-12 |
| CN103025340B (zh) | 2014-12-24 |
| SG186999A1 (en) | 2013-02-28 |
| EP2595643A4 (en) | 2013-12-25 |
| US20120022018A1 (en) | 2012-01-26 |
| AP2013006738A0 (en) | 2013-02-28 |
| HK1182336A1 (en) | 2013-11-29 |
| EP2595643A1 (en) | 2013-05-29 |
| WO2012012513A1 (en) | 2012-01-26 |
| MX2013000670A (es) | 2013-02-27 |
| NZ605466A (en) | 2015-04-24 |
| BR112013001717A2 (pt) | 2016-05-31 |
| ZA201300583B (en) | 2014-06-25 |
| AU2011282200A1 (en) | 2013-01-24 |
| JP2013531071A (ja) | 2013-08-01 |
| TW201206460A (en) | 2012-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR082335A1 (es) | Propiedades antivirales del aloe-vera y tratamiento del sindrome de inmunodeficiencia adquirida (sida) | |
| AR076676A1 (es) | Lactobacillus johnsonii la1 ncc533 (cncm i-1225) y trastornos inmunes | |
| NZ726746A (en) | Stable cannabinoid formulations | |
| ES2500840T3 (es) | Uso de composiciones farmacéuticas en la preparación de productos farmacéuticos para tratar úlcera diabética | |
| AR114353A1 (es) | Composiciones sólidas que comprenden un agonista del glp-1 y una sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico | |
| CL2019002640A1 (es) | Moléculas propioticas para reducir virulencia de patógenos. | |
| CL2020000632A1 (es) | Composición y método para el tratamiento del autismo. | |
| AR103371A1 (es) | Composiciones y métodos para diagnosis y tratamiento de síndrome metabólico, uso | |
| CO2018009538A2 (es) | Uso de cepas bacterianas pertenecientes a la especie lactobacillus kefiri en pediatría para generar y/o mantener un estado de homeostasis | |
| CL2019000447A1 (es) | Composiciones y métodos para detección de proteína smn en un sujeto y tratamiento de un sujeto. (divisional solicitud 201700594) | |
| AR115283A1 (es) | Composiciones sólidas que comprenden un agonista del glp-1 y una sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílicoe | |
| CO2022000578A2 (es) | Composiciones sólidas que comprenden un agonista del glp-1, un inhibidor del sglt2 y una sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico | |
| PE20211489A1 (es) | Formas de dosificacion pediatricas de vitamina d, metodos de elaboracion y uso | |
| ES2517741B1 (es) | Composición para reducir y/o prevenir la caída del cabello y/o estimular su crecimiento | |
| CL2011003235A1 (es) | Alimento de peces que contiene por lo menos un antioxidante soluble en agua seleccionado del grupo acidos hidroxicinamicos o acidos hidrobenzoicos, contiene hasta 40 mg de pigmento por kilo de alimento de por lo menos un pigmento seleccionado del grupo que comprende astaxantina o cantaxantina. | |
| ES2425294B1 (es) | Compuestos derivados de sulforafano, método de obtención y su uso médico, alimenticio y cosmético | |
| AR122299A1 (es) | Composiciones sólidas que comprenden un inhibidor de pcsk9 y una sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico | |
| PE20142324A1 (es) | Composicion farmaceutica para el tratamiento de incontinencia urinaria y enuresis | |
| AR091818A1 (es) | Pañal descartable | |
| AR082653A1 (es) | Composicion farmaceutica topica que comprende heparina | |
| WO2015104298A3 (de) | Polyphenol-konjugate | |
| MX361765B (es) | Formulacion homogenea que comprende acido graso poliinsaturado omega-3 y resveratrol para administracion oral. | |
| GT201400115A (es) | Combinación farmacéutica antineurítica y composición | |
| CL2019003288A1 (es) | Una combinación farmacéutica para el tratamiento de un cáncer. | |
| CL2017002828A1 (es) | Composición para tratamiento de estrés oxidativo y enfermedad cardiovascular |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |